Rankings
▼
Calendar
ELAN FY 2017 Earnings — Elanco Animal Health Incorporated Revenue & Financial Results | Market Cap Arena
ELAN
Elanco Animal Health Incorporated
$12B
FY 2017 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$2.9B
-0.8% YoY
Gross Profit
$1.2B
40.6% margin
Operating Income
$142M
4.9% margin
Net Income
-$311M
-10.8% margin
EPS (Diluted)
$-0.87
Cash Flow
Operating Cash Flow
$174M
Free Cash Flow
$75M
Stock-Based Comp.
$25M
Balance Sheet
Total Assets
$8.9B
Total Liabilities
$1.1B
Stockholders' Equity
$7.8B
Cash & Equivalents
$323M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2.9B
$2.9B
-0.8%
Gross Profit
$1.2B
$1.3B
-12.0%
Operating Income
$142M
$283M
-49.7%
Net Income
-$311M
-$48M
-548.6%
← FY 2016
All Quarters
Q1 2017 →